slotkoers
Dhaka S.E.
00:00:00 25-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
189,9
BDT
|
-2,96%
|
|
-5,57%
|
-22,49%
|
Fiscaal tijdperk: Juni |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
4.112
|
4.643
|
14.022
|
28.552
|
59.667
|
56.595
|
Bedrijfswaarde
1 |
5.462
|
6.132
|
15.590
|
30.705
|
62.950
|
63.573
|
K/w-verhouding
|
32,6
x
|
39,4
x
|
36,8
x
|
33,1
x
|
63,8
x
|
111
x
|
Dividendrendement
|
3,37%
|
2,49%
|
-
|
1,21%
|
0,62%
|
0,65%
|
Marktkapitalisatie/omzet
|
1,09
x
|
1
x
|
2,51
x
|
4,01
x
|
7,44
x
|
6,65
x
|
Bedrijfswaarde/omzet
|
1,45
x
|
1,32
x
|
2,79
x
|
4,31
x
|
7,85
x
|
7,47
x
|
Bedrijfswaarde/EBITDA
|
7,2
x
|
7,1
x
|
18,5
x
|
17,6
x
|
30,6
x
|
42,8
x
|
Bedrijfswaarde/FCF
|
-146
x
|
-367
x
|
-67,9
x
|
-54,6
x
|
-54,9
x
|
-18,2
x
|
FCF Yield
|
-0,69%
|
-0,27%
|
-1,47%
|
-1,83%
|
-1,82%
|
-5,5%
|
Price to Book
|
1,37
x
|
1,56
x
|
3,03
x
|
5,33
x
|
10
x
|
9,52
x
|
Aantal aandelen (in duizenden)
|
231.000
|
231.000
|
231.000
|
231.000
|
231.000
|
231.000
|
Referentieprijs
2 |
17,80
|
20,10
|
60,70
|
123,6
|
258,3
|
245,0
|
Datum van publicatie
|
15/11/18
|
27/11/19
|
20/12/21
|
20/12/21
|
22/11/22
|
5/12/23
|
Fiscaal tijdperk: Junio |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
3.761
|
4.647
|
5.591
|
7.121
|
8.023
|
8.510
|
EBITDA
1 |
758,7
|
863,4
|
844,5
|
1.747
|
2.057
|
1.487
|
Bedrijfsresultaat (EBIT)
1 |
263,3
|
314,4
|
333,5
|
1.362
|
1.617
|
967,7
|
Operationele Marge
|
7%
|
6,77%
|
5,96%
|
19,12%
|
20,16%
|
11,37%
|
Resultaat voor belastingen (EBT)
1 |
126
|
163,4
|
184,5
|
1.198
|
1.293
|
679,1
|
Nettowinst (verlies)
1 |
126,1
|
117,7
|
380,7
|
863,2
|
935
|
509,8
|
Nettomarge
|
3,35%
|
2,53%
|
6,81%
|
12,12%
|
11,65%
|
5,99%
|
WPA
2 |
0,5459
|
0,5095
|
1,648
|
3,737
|
4,048
|
2,207
|
Free Cash Flow
1 |
-37,47
|
-16,71
|
-229,6
|
-562
|
-1.146
|
-3.498
|
FCF-marge
|
-1%
|
-0,36%
|
-4,11%
|
-7,89%
|
-14,28%
|
-41,1%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
2 |
0,6000
|
0,5000
|
-
|
1,500
|
1,600
|
1,600
|
Datum van publicatie
|
15/11/18
|
27/11/19
|
20/12/21
|
20/12/21
|
22/11/22
|
5/12/23
|
Fiscaal tijdperk: Juni |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
1.350
|
1.488
|
1.568
|
2.153
|
3.282
|
6.978
|
Nettokaspositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
1,779
x
|
1,724
x
|
1,857
x
|
1,233
x
|
1,596
x
|
4,694
x
|
Free Cash Flow
1 |
-37,5
|
-16,7
|
-230
|
-562
|
-1.146
|
-3.498
|
ROE (netto-inkomsten/eigen vermogen)
|
4,21%
|
3,94%
|
10%
|
17,3%
|
16,6%
|
8,58%
|
ROA (netto-inkomsten/totale activa)
|
3,29%
|
4,02%
|
3,46%
|
10,8%
|
10,4%
|
4,75%
|
Totale activa
1 |
3.837
|
2.929
|
11.003
|
7.968
|
8.951
|
10.730
|
Nettoactief per aandeel
2 |
13,00
|
12,90
|
20,00
|
23,20
|
25,70
|
25,70
|
Cashflow per aandeel
2 |
0,3700
|
1,220
|
2,590
|
1,460
|
2,330
|
1,960
|
Capex
1 |
324
|
244
|
314
|
313
|
1.719
|
1.814
|
Capex/omzet
|
8,61%
|
5,24%
|
5,62%
|
4,4%
|
21,43%
|
21,32%
|
Datum van publicatie
|
15/11/18
|
27/11/19
|
20/12/21
|
20/12/21
|
22/11/22
|
5/12/23
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -22,49% | 400 mln. | | +19,62% | 43,34 mld. | | +20,44% | 21,96 mld. | | +10,86% | 14,09 mld. | | +13,07% | 13,64 mld. | | +37,46% | 11,43 mld. | | -8,59% | 6,86 mld. | | -0,05% | 6,79 mld. | | -8,87% | 5,73 mld. | | +8,46% | 5,22 mld. |
Generieke geneesmiddelen
|